Insight Molecular Diagnostics Inc. Payments of Stock Issuance Costs
Insight Molecular Diagnostics Inc. (IMDX) reported Payments of Stock Issuance Costs of $1.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $185.00K.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for the quarter ending 2026-03-31 was $1.18M, a 142.92% increase year-over-year.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for fiscal 2025 was $487.00K, a 64.56% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for fiscal 2024 was $1.37M, a 221.78% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for fiscal 2023 was $427.00K, a 9.77% increase from fiscal 2022.
- Insight Molecular Diagnostics Inc. payments of stock issuance costs for fiscal 2022 was $389.00K, a 85.46% decline from fiscal 2021.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.37M 10-Q · filed 2026-08-10 | $1.37M derived: sum of 3 quarters · filed 2026-08-10 | $1.37M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-13 | $1.18M derived: sum of 2 quarters · filed 2026-05-13 | $1.18M derived: sum of 3 quarters · filed 2026-05-13 | $1.18M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $487.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $487.00K 10-Q · filed 2025-11-10 | $1.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $487.00K 10-Q · filed 2026-08-10 | $1.32M derived: sum of 3 quarters · filed 2026-08-10 | $1.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $487.00K 10-Q · filed 2026-05-13 | $1.32M derived: sum of 2 quarters · filed 2026-05-13 | $1.32M derived: sum of 3 quarters · filed 2026-05-13 | $1.86M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $836.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $836.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.37M derived: sum of 3 quarters · filed 2026-03-26 | $1.37M 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $538.00K derived: sum of 2 quarters · filed 2025-11-10 | $538.00K 10-Q · filed 2025-11-10 | $538.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $538.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $538.00K 10-Q · filed 2025-08-11 | $538.00K derived: sum of 3 quarters · filed 2025-08-11 | $538.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-12 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $427.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $427.00K 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | $427.00K 10-Q · filed 2024-08-08 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $389.00K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $389.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $389.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | -$1.00K derived: sum of 2 quarters · filed 2023-04-12 | -$1.00K derived: sum of 3 quarters · filed 2023-04-12 | $2.67M 10-K · filed 2023-04-12 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $2.68M 10-Q · filed 2022-11-10 | $2.68M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $2.68M 10-Q · filed 2022-08-12 | $2.68M derived: sum of 3 quarters · filed 2022-08-12 | $2.70M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $2.68M 10-Q · filed 2022-05-12 | $2.68M derived: sum of 2 quarters · filed 2022-05-12 | $2.70M derived: sum of 3 quarters · filed 2022-05-12 | $2.73M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $27.00K derived: sum of 2 quarters · filed 2022-03-11 | $57.00K derived: sum of 3 quarters · filed 2022-03-11 | $58.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $57.00K derived: sum of 2 quarters · filed 2021-11-09 | $58.00K 10-Q · filed 2021-11-09 | $94.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $31.00K 10-Q · filed 2021-08-11 | $67.00K derived: sum of 3 quarters · filed 2021-08-11 | $67.00K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-17 | $37.00K derived: sum of 2 quarters · filed 2021-05-17 | $37.00K derived: sum of 3 quarters · filed 2021-05-17 | $324.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $36.00K derived: sum of 2 quarters · filed 2021-03-19 | $323.00K derived: sum of 3 quarters · filed 2021-03-19 | $3.29M 10-K · filed 2021-03-19 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $287.00K derived: sum of 2 quarters · filed 2020-11-12 | $3.25M 10-Q · filed 2020-11-12 | $3.25M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $287.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $3.25M 10-Q · filed 2020-07-29 | $3.25M derived: sum of 3 quarters · filed 2020-07-29 | $3.25M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $2.96M 10-Q · filed 2020-05-12 | $2.96M derived: sum of 2 quarters · filed 2020-05-12 | $2.96M derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $65.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $65.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $65.00K 10-Q · filed 2019-08-14 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | ||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |||
| 2016-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $773.00K 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $800.00K 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 10-K · filed 2018-04-02 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |